Quick Answer
XBiotech Inc. reported Operating Income of -$55.69 million for fiscal year 2025.
XBiotech Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$55.69M | -31.1% |
| 2024 | -$42.47M | -13.2% |
| 2023 | -$37.51M | -8.8% |
| 2022 | -$34.49M | -37.5% |
| 2021 | -$25.08M | -37.2% |
| 2020 | -$18.28M | +41.5% |
| 2019 | -$31.23M | -48.8% |
| 2018 | -$20.99M | +38.4% |
| 2017 | -$34.06M | +35.4% |
| 2016 | -$52.76M | -40.7% |
| 2015 | -$37.51M | -72.2% |
| 2014 | -$21.78M | -119.4% |
| 2013 | -$9.93M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$6.05M | +23.5% | +4.6% |
| June 30, 2025 | -$6.34M | +57.7% | +53.2% |
| March 31, 2025 | -$13.55M | -24.9% | -71.4% |
| September 30, 2024 | -$7.90M | +7.2% | +47.2% |
| June 30, 2024 | -$14.97M | -12.9% | -37.9% |
| March 31, 2024 | -$10.85M | -51.9% | -27.4% |
| September 30, 2023 | -$8.52M | -33.4% | +35.7% |
| June 30, 2023 | -$13.26M | -9.6% | -85.6% |
- XBiotech Inc. showed a decrease of -31.1% in Operating Income compared to the prior fiscal year.
- Over the 2013–2025 period, XBiotech Inc.’s operating income has declined by 461.1% (from -$9.93 million to -$55.69 million).
- The most recent figure is from XBiotech Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: